Download 3

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Management of acute coronary syndrome wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Mitral insufficiency wikipedia , lookup

Antihypertensive drug wikipedia , lookup

Jatene procedure wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Dextro-Transposition of the great arteries wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Transcript
Chapter
3
Accurate assessment of loadindependent right ventricular
systolic function in patients with
pulmonary arterial hypertension
P. Trip
T. Kind
M.C. van de Veerdonk
J.T. Marcus
F.S. de Man
N. Westerhof
A. Vonk Noordegraaf
J Heart Lung Transplant 2013; 32: 50-55
37
Chapter 3
ABSTRACT
Background
End-systolic elastance (Ees), a load-independent measure of ventricular
function, is of clinical interest for studies on the right ventricle (RV) in
patients with pulmonary arterial hypertension (PAH). The objective of
this study is to determine whether in PAH patients Ees can be estimated
from mean pulmonary artery pressure (mPAP) and end-systolic volume
(ESV) only.
Methods
Right heart catheterisation was used to measure mPAP. Maximal
isovolumic pressure (Piso) was estimated from RV pressure curves with
the so-called single-beat method as published by Sunagawa. Cardiac MRI
was used to assess RV end-diastolic and end-systolic volumes (EDV and
ESV). Ees was then calculated as: Ees = (Piso-mPAP)/(EDV-ESV), and as
Ees,V0=0 = mPAP/ESV (simplified method, with V0=0 is negligible volume
at zero pressure). Right ventricular volume at zero pressure (V0) was then
defined as the intercept of the end-systolic pressure-volume relation
(single-beat method) with the horizontal axis.
Results
Ees,V0=0 was significantly lower compared to Ees (0.61 vs. 1.34 mmHg/ml
respectively, p < 0.01). A modified Bland-Altman analysis showed a
contractility-dependent difference between Ees,V0=0 and Ees. Moreover,
V0 ranged from -8 up to 171 ml, and a moderate and good correlation
was found between V0 and EDV, and V0 and ESV respectively (r = 0.65
and r=0.87, p < 0.01).
Conclusions
These findings illustrate that V0 is dependent on RV dilation. Therefore,
the assumption that V0 is negligible in PAH is incorrect. Consequently,
for an accurate assessment of load independent RV systolic function, RV
volumes and pressure curves are required.
38
Chapter 3
INTRODUCTION
Pulmonary arterial hypertension (PAH) is a condition characterized by increased pulmonary artery
pressure as a result of pulmonary vascular remodeling. Although it is the pulmonary vasculature that
is affected, patients die of right heart failure1. The importance of right ventricular (RV) function in PAH
is further reflected by the prognostic significance of RV ejection fraction and other RV functional
parameters2-6. Although useful, all of these parameters are dependent on loading conditions and
therefore do not characterize intrinsic RV function7,8. An RV functional parameter that is accepted as
load-independent is end-systolic elastance (Ees), a measure of myocardial contractility9,10. Because of
the load-independency, this parameter is of potential interest for studies on the right ventricle in PAH.
From a clinical point of view, the assessment of RV function independent of load is important for the
estimation of RV function after normalization of arterial load, such as after lung transplantation in
patients with severe pulmonary hypertension.
Until now, the clinical use of Ees in PAH patients is still very limited since accurate determination of Ees
is hampered by the requirement of invasive interventions. Namely the classical approach to determine
Ees requires pressure-volume loop analysis with (partial) vena cava occlusion, which is not only
technically demanding but also dangerous in PAH patients. A simplified single-beat approach has been
developed by Sunagawa et al. (FIGURE 3.1, left)11,12, not requiring pressure-volume loops and vena
cava occlusion. Although proven to be accurate for the right ventricle13,14, this method still requires
measurement of RV pressure curves in combination with the assessment of RV volumes or pulmonary
artery flow. Since cardiac MRI and RV pressure curves are not available in every PAH-center, this
method is still not widely applicable.
More recently, an approach to estimate RV Ees (FIGURE 3.1, right) in PAH patients has been used15.
This approach, first applied to the left ventricle and thereafter frequently used16-20, estimates Ees by
dividing mean pulmonary artery pressure (assumed equal to end-systolic pressure) by end-systolic
volume (ESV). With this method Ees can be easily calculated in large groups of PAH patients.
Furthermore, ventricular-arterial coupling, a measure of how well cardiac and vascular function are
matched, can be then be assessed non-invasively15. In spite of its advantages, the method has never
been validated with an accepted standard for the assessment of RV function. Therefore, the aim of
this study is to determine whether RV Ees can be estimated from mPAP and ESV only.
39
Chapter 3
A. Ees
B.
Ees,V0=0
Pressure
Pressure
Piso
Ees
mPAP
mPAP
Ees
V0
ESV
Volume
EDV
ESV
Volume
FIGURE 3.1 Schematic presentation of a pressure-volume loop showing the two methods to calculate Ees. A. Single-beat estimation
of Ees. The grey area represents the triangle which is used to calculate the slope (E es) of the end-systolic pressure-volume relation
(ESPVR) which is the line connecting Piso with mPAP. With this method, the line can be continued until it intercepts the horizontal
axis at a certain value. This value represents the volume at zero pressure (V 0) and can either be a negative or a positive value. B.
Ees estimated by mPAP/ESV. The line of ESPVR is drawn through the origin of the graph, thereby neglecting V 0. In every patient V0
is assumed to be zero. Piso; RV isovolumic pressure, mPAP; mean pulmonary artery pressure, EDV; RV end-diastolic volume, ESV;
RV end-systolic volume, V0; volume at zero pressure, Ees; end-systolic elastance.
METHODS
Subjects
Patients referred to the VU university medical center for evaluation of PAH and patients with PAH
undergoing follow-up analysis were retrospectively included in this study. Standard clinical care
included right heart catheterization with digital recordings of pressures and cardiac MRI. A total of 28
patients were selected based on: 1. diagnosis of idiopathic pulmonary arterial hypertension (IPAH),
and 2. available recordings of qualitative good RV pressure curves and cardiac MRI (for RV volumes)
within two days of each other. Inclusion period was January 2003 to April 2009. Idiopathic PAH was
defined as pulmonary hypertension for which no cause could be identified with a measured mean
40
Chapter 3
pulmonary artery pressure (mPAP) > 25 mmHg and a pulmonary capillary wedge pressure (PCWP) <15
mmHg. Due to the retrospective character of the study using data obtained for clinical purposes the
Medical Ethics Review Committee of the VU University Medical Center did not consider this study to
fall within the scope of the Medical Research Involving Human Subjects Act. Therefore, no additional
approval was acquired.
Right heart catheterization
Under local anesthesia, a balloon-tipped Swan-Ganz catheter (Edwards Lifesciences, LLC, Irvine, CA)
was inserted via the jugular vein and brought into position. Under constant ECG monitoring,
pulmonary artery and right ventricular pressures were measured. Alongside the standard pressure
recordings, pressure curves were registered using a Powerlab data acquisition system (AD
Instruments, Sydney, Australia). For our measurements we used shielded pressure transducers with a
resistance serially connected to increase damping. For each measurement we assured that no
oscillations were obtained in the pressure signal. Moreover, the catheter was repeatedly flushed with
heparin to avoid potential underdamping due to blood clots.
Mean PAP was averaged over at least two respiratory cycles. Cardiac output was measured by the
direct Fick method in 26 patients and by thermodilution in 2 patients. Stroke volume was calculated
as cardiac output divided by heart rate. Cardiac output and stroke volume were indexed for body
surface area (BSA). PCWP was taken at end-expiration. Pulmonary vascular resistance was calculated
as the difference between mPAP and PCWP divided by cardiac output.
Cardiac magnetic resonance imaging
All MR images were acquired with a 1.5 Tesla Avanto or Sonata MRI system equipped with a 6-element
phased array coil (Siemens Medical Solutions, Erlangen, Germany). A stack of short-axis images was
taken at breath-hold per slice, with a slice thickness and interslice gap of 5mm. Both ventricles were
covered. To obtain RV volumes, endocardial borders were manually drawn at end-diastole and endsystole using Mass Analysis software (MEDIS Medical Imaging Systems, Leiden, The Netherlands). Enddiastole was defined as the onset of the R-wave of the ECG. End-systole was determined visually as
the smallest volume during the cardiac cycle. Volume measurements were indexed for body surface
area (BSA). RV ejection fraction (RVEF) = RVEDV-RVESV*100%, where RVEDV is RV end-diastolic
volume and RVESV is RV end-systolic volume.
41
Chapter 3
Data analysis and calculations
End-systolic elastance
RV isovolumic pressure (Piso) per beat was determined according the single-beat method of
Sunagawa11-13. An inverted cosine wave was fitted over the RV pressure curve using the isovolumic
contraction period (from end-diastole to the point of maximal rate of pressure rise (dP/dtmax)) and the
isovolumic relaxation period (from minimal dP/dt to start diastole) by a semi-automatic Matlab
R2008a program (The MathWorks, Natick, MA). The point of end-diastole was identified using the Rwave of the ECG, and when needed manually shifted to the point before the upslope of the ascending
limb. To compensate for beat-to-beat variations, the so calculated RV isovolumic pressures were
averaged over at least five heartbeats. Beats with significant catheter artefacts were excluded.
The slope of the ESPVR was calculated using the single beat method (E es), and estimated using mean
pressure and end-systolic volume (Ees,V0=0) as follows (FIGURE 3.1):
Ees
= (Piso-mPAP)/(EDV-ESV)
Ees,V0=0
= mPAP/ESV
= (Piso-mPAP)/SV
Piso is RV isovolumic pressure estimated by the single-beat method, mPAP is mean pulmonary artery
pressure taken as a surrogate of RV end-systolic pressure21-23, EDV, ESV, and SV are RV end-diastolic,
end-systolic and stroke volume, respectively.
Volume at zero pressure (V0)
V0 is volume at zero pressure and was defined as the intercept of the (linear) end-systolic pressure
volume relationship with the horizontal axis (FIGURE 3.1a). In addition, V0-values of individual patients
(without pulmonary hypertension) who had undergone multiple pressure-volume loop analysis
together with RV volume measurements were collected from literature for comparison24.
Statistical analysis
The data are presented as median with range. The Wilcoxon signed rank test was used to compare
the values of two methods. A p-value of < 0.05 was considered significant. The correlation between
the two methods and between V0 and RV end-diastolic and end-systolic volume was assessed by the
Pearson’s or Spearman’s method when data was normally or not normally distributed, respectively.
Linear regressions were performed using the least-squares method. Bland-Altman analysis was
performed to determine the agreement between the two methods. Since mean bias was not well
42
Chapter 3
described by one value, a modified Bland-Altman analysis was applied to compute the 95% limits of
agreement25.
TABLE 2.1 Patient characteristics
Characteristics
Age (years)
Male (%)
BSA (m2)
mPAP (mmHg)
mRAP (mmHg)
CI (L/min/m2)
Heart rate (beats/min)
SVI (ml/m2)
PVR (dyn-s-cm-5)
RVEDVI (ml/m2)
RVESVI (ml/m2)
RVEF (%)
Ees (mmHg/ml)
Ees,V0=0 (mmHg/ml)
V0 (ml)
Median
Range
43
14
1.76
51
6
2.5
86
31
800
68
42
39
1.34
0.61
43
21-64
1.53-2.33
30-77
0-18
1.1-7.4
56-101
14-89
188-1969
46-169
24-130
18-65
0.36-3.88
0.22-1.13
-8-171
mPAP, mean pulmonary artery pressure; mRAP, mean right atrial pressure; CI, cardiac index; PVR,
pulmonary vascular resistance; RVEDVI, right ventricular end-diastolic volume index; RVESVI, right
ventricular end-systolic volume index; RVEF, right ventricular ejection fraction; E es and Ees,V0=0, endsystolic elastance measured by the single beat method and the method mPAP/ESV with V 0=0,
respectively.
RESULTS
Patient characteristics and both Ees and Ees,V0=0 are shown in TABLE 3.1. The patients (n=28) included
represent IPAH patients over a wide range of disease severity, as is reflected by the range in PVR (1881969 dynes-s-cm-5), RV ejection fraction (18-65 %), and stroke volume index (14-89 ml/m2). Out of 28
patients, 24 patients were under treatment at the moment of inclusion, the other 4 patients were not
yet treated
Ees: comparison of two methods
End-systolic elastance was significantly higher compared to the Ees,V0=0 (1.34 vs. 0.61 mmHg/ml
respectively, p < 0.01). As shown in FIGURE 3.2a, a moderate correlation was found between the two
43
Chapter 3
methods (r = 0.51, p < 0.05). A modified Bland-Altman analysis is given in FIGURE 3.2b. which shows
that at higher values of Ees the difference between Ees and the Ees,V0=0 increases.
FIGURE 3.2. A. Linear regression analysis of the correlation between E es and Ees,V0=0. Line of equality is given. Dashed lines = 95%
confidence interval. B. Modified Bland-Altman plot of agreement between Ees and Ees,V0=0.
FIGURE 3.3 Linear regression analysis of the correlation between RV end-systolic volume and V0 in this study (patients with
idiopathic pulmonary arterial hypertension, open dots) and in a study published by Dell’Italia (patients referred for cardiac
catheterization for evaluation of chest pain by whom no abnormalities were found, closed dots)24.
Volume at zero pressure
V0 ranged from -8 to 171 ml. A moderate
correlation was found between V0 and EDV (r =
0.65, p < 0.01). A stronger correlation between V0
and ESV was found (FIGURE 3.3, r = 0.87, p <
0.01). We additionally plotted ESV- and V0-values
reported in the study published by Dell’Italia24,
and a similar dependence but a stronger
correlation was found between ESV and V0
(FIGURE 3.3, r = 0.95, p < 0.01). The slopes of the
regression lines of these two data sets were not
statistically different (this study; 0.88 ± 0.08,
44
Chapter 3
Dell’Italia; 0.79 ± 0.10, p = 0.68). However, the Y-axis intercept was significantly lower in the present
study (-29 ± 7 vs. 2 ± 6 mm Hg, p < 0.01).
DISCUSSION
Our study shows that in PAH patients, the estimation of E es based on mPAP and end-systolic volume
strongly underestimates Ees. Therefore, this method cannot be applied in patients with PAH, as will be
discussed below. Furthermore, V0 was highly dependent on RV dilation suggested by the close
association between RV volumes and V0. The assumption that V0 is negligible in PAH patients is
therefore incorrect.
V0 in healthy controls and PAH patients and the consequence of neglecting its value
The estimated Ees is calculated by dividing mPAP by RV end-systolic volume (Ees,V0=0) and is based on
the assumption that V0 is negligible. V0 is the volume that would be left in the ventricle after
contraction against zero load, and is often called dead volume, i.e. V d or V0. For the left ventricle it is
known that neglecting V0 in the Ees-calculation leads to a consistent and severe overestimation of Ees
as measured by multiple-loop analysis26. For the right ventricle the consequence of neglecting V 0 is
not known.
There are only a few studies reporting right ventricular V0-values in humans. In a study of Dell’Italia et
al. subjects without underlying cardiovascular disease underwent multiple pressure-volume loop
analysis and V0 was calculated using a linear ESPVR. They found right ventricular V 0 to range from 24
up to 89 ml24. Brown et al. analyzed eight patients, also with a linear approach, and found V0-values
to range from -8 ml/m2 to 28 ml/m2 27. With this wide range in V0 in normotensive patients there
seems to be no reason to assume V0 is negligible. Indeed, we show in PAH patients an even wider
range of V0, making it even less appropriate to neglect V0 in this patient category. The assumption that
V0 is zero for all PAH patients has as a consequence that Ees is severely underestimated, as is shown in
FIGURE 3.1. Furthermore, the limited range in Ees,V0=0 makes this method less usable for discrimination
between patients.
Correlation of V0 with RV volumes
The wide range in V0 in humans and especially in PAH patients, might be explained by the dependence
of V0 on muscle length at end-systole at zero load. Since muscle length is never zero, V0 will never be
45
Chapter 3
zero. And since muscle length is presumably increased in PAH patients in case of eccentric
remodelling, this patient category will have higher V0-values compared to persons with non-dilated
ventricles.
The theory above suggests a positive relation between ventricular volume and V 0. This relationship
has never been reported for the RV though. However, for the left ventricle it is known that V 0 is smaller
in patients with a normal ejection fraction, compared to patients with a lower ejection fraction28,29.
Patients with a low ejection fraction did have larger end-diastolic and end-systolic volumes. In our
present study, a moderate correlation between RV end-diastolic volume and V0, and a stronger
correlation between V0 and RV end-systolic volume was found. This correlation was confirmed in data
from multiple pressure-volume loop analysis of Dell’Italia et al.24. The latter is not only confirming the
existence of a relationship between RV volume and V0, but also underlines the reliability of the singlebeat estimation of end-systolic elastance.
The stronger correlation between RV end-systolic volume and V0 compared to RV end-diastolic
volume and V0 may be explained by the greater intra- and inter-observer variability of the
quantification of RV end-diastolic volume30.
Then, the finding of the V0-ESV relation raises the question whether one can estimate V 0 when
knowing end-systolic volume. In this study a considerable scatter around the regression line of V 0-ESV
was found. Therefore, we do not recommend to estimate V 0 based on ESV. However, it may be that
an acceptable estimation of V0 can be made using both ESV and EDV. Future studies will be needed to
answer this question.
Clinical implications
The findings of this study imply that the estimation of RV Ees using mPAP/ESV does not reflect RV
contractility, but may rather be a load-dependent measure of systolic function. Therefore, to describe
RV contractility in PAH patients the estimation should not be used. Instead, one should use the singlebeat method as published by Sunagawa, and validated for the RV by Brimioulle, since no better
alternative methods are presently available11,13. Furthermore, the finding that RV-arterial coupling
can be assessed non-invasively by cardiac MRI, using the simplified method, should therefore be
revised15.
46
Chapter 3
Study limitations
In the calculation of Ees usually RV end-systolic pressure is used and not mPAP. In this study we chose
to substitute RV end-systolic pressure by mPAP in both Ees-calculations and not to focus on the
difference between RV end-systolic pressure and mPAP. As a consequence, the difference found
between the two methods is only the result of the magnitude of V0-values.
In this study, pressure and volumes could not be measured simultaneously which may have influenced
the results due to differences in the patients’ stress level. However, we measured heart rates during
both measurements and found an excellent correlation between the two values (r 0.87, p<0.001)
suggesting a similar amount of stress and therefore a negligible effect of stress on the study results.
We used fluid-filled catheters to measure RV pressures, taking special care to prevent under- and
overdamping of the pressure signal and excluded data showing RV pressure tracings with catheter
artifacts. Kuehne et al. showed that data obtained in this way is in good agreement with data obtained
by catheter-tip manometers14.
CONCLUSIONS
In PAH patients, the estimation of right ventricular contractility using Ees,V0=0 from the ratio of mean
pulmonary artery pressure and end-systolic volume is inaccurate. Consequently, for an accurate
assessment of RV systolic function, and ventriculo-arterial coupling, RV volumes and pressure curves
are required.
Disclosures
No conflicts of interest, financial or otherwise, are declared by the authors.
Grants
Anton Vonk Noordegraaf was supported by Netherlands Organisation for Scientific Research (NWO)VIDI ( project number 917.96.306).
47
Chapter 3
REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and
Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006;114:188391.
Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am
J Respir Crit Care Med 2006;174:1034-41.
Ghio S, Klersy C, Magrini G, et al. Prognostic relevance of the echocardiographic assessment of right ventricular
function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 2010;140:272-8.
Sachdev A, Villarraga HR, Frantz RP, et al. Right ventricular strain for prediction of survival in patients with pulmonary
arterial hypertension. Chest 2011;139:1299-309.
van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary
arterial hypertension responding to therapy. J Am Coll Cardiol 2011;58:2511-9.
van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in
idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28:1250-7.
Ferferieva V, Van den Bergh A, Claus P, et al. The relative value of strain and strain rate for defining intrinsic myocardial
function. Am J Physiol Heart Circ Physiol 2012;302:H188-95.
Kass DA, Maughan WL, Guo ZM, et al. Comparative influence of load versus inotropic states on indexes of ventricular
contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation 1987;76:142236.
Maughan WL, Shoukas AA, Sagawa K, et al. Instantaneous pressure-volume relationship of the canine right ventricle.
Circ Res 1979;44:309-15.
Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left
ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 1973;32:314-22.
Sunagawa K, Yamada A, Senda Y, et al. Estimation of the hydromotive source pressure from ejecting beats of the left
ventricle. IEEE Trans Biomed Eng 1980;27:299-305.
Takeuchi M, Igarashi Y, Tomimoto S, et al. Single-beat estimation of the slope of the end-systolic pressure-volume
relation in the human left ventricle. Circulation 1991;83:202-12.
Brimioulle S, Wauthy P, Ewalenko P, et al. Single-beat estimation of right ventricular end-systolic pressure-volume
relationship. Am J Physiol Heart Circ Physiol 2003;284:H1625-30.
Kuehne T, Yilmaz S, Steendijk P, et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops:
in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 2004;110:2010-6.
Sanz J, Garcia-Alvarez A, Fernandez-Friera L, et al. Right ventriculo-arterial coupling in pulmonary hypertension: a
magnetic resonance study. Heart 2012;98:238-43.
Chantler PD, Melenovsky V, Schulman SP, et al. The sex-specific impact of systolic hypertension and systolic blood
pressure on arterial-ventricular coupling at rest and during exercise. Am J Physiol Heart Circ Physiol 2008;295:H14553.
Grosu A, Bombardini T, Senni M, et al. End-systolic pressure/volume relationship during dobutamine stress echo: a
prognostically useful non-invasive index of left ventricular contractility. Eur Heart J 2005;26:2404-12.
Saba PS, Roman MJ, Ganau A, et al. Relationship of effective arterial elastance to demographic and arterial
characteristics in normotensive and hypertensive adults. J Hypertens 1995;13:971-7.
Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance
at rest and during exercise. J Appl Physiol 2008;105:1342-51.
Najjar SS, Schulman SP, Gerstenblith G, et al. Age and gender affect ventricular-vascular coupling during aerobic
exercise. J Am Coll Cardiol 2004;44:611-7.
Chemla D, Hebert JL, Coirault C, et al. Matching dicrotic notch and mean pulmonary artery pressures: implications for
effective arterial elastance. Am J Physiol 1996;271:H1287-95.
Curtiss EI, Reddy PS, O'Toole JD, et al. Alterations of right ventricular systolic time intervals by chronic pressure and
volume overloading. Circulation 1976;53:997-1003.
Dell'Italia LJ, Santamore WP. Can indices of left ventricular function be applied to the right ventricle? Prog Cardiovasc
Dis 1998;40:309-24.
Dell'Italia LJ, Walsh RA. Application of a time varying elastance model to right ventricular performance in man.
Cardiovasc Res 1988;22:864-74.
Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-60.
Chen CH, Fetics B, Nevo E, et al. Noninvasive single-beat determination of left ventricular end-systolic elastance in
humans. J Am Coll Cardiol 2001;38:2028-34.
Brown KA, Ditchey RV. Human right ventricular end-systolic pressure-volume relation defined by maximal elastance.
Circulation 1988;78:81-91.
48
Chapter 3
28.
29.
30.
Asanoi H, Sasayama S, Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ Res
1989;65:483-93.
Grossman W, Braunwald E, Mann T, et al. Contractile state of the left ventricle in man as evaluated from end-systolic
pressure-volume relations. Circulation 1977;56:845-52.
Bradlow WM, Hughes ML, Keenan NG, et al. Measuring the heart in pulmonary arterial hypertension (PAH):
implications for trial study size. J Magn Reson Imaging 2010;31:117-24.
49
Chapter 3
SUPPLEMENTAL DATA
FIGURE 3.1S. Schematic presentation of the single-beat estimation of RV isovolumic pressure and
the calculation of end-systolic elastance.
A.
B.
Piso
Pes
Ppa
Pressure
Piso
Ees
Pes
Ea
PRV
Isovolumic part of
the pressure curve
A.
ESV
Volume
EDV
RV isovolumic pressure (Piso) per beat was determined according the single-beat method of Sunagawa11-13. An inverted
cosine wave was fitted over the RV pressure curve using the isovolumic contraction period (see pressure points within
the grey area). The data points used start at end-diastole and continue to the point of maximal rate of pressure rise
(dP/dtmax). In addition, the points within the isovolumic relaxation period (from minimal dP/dt to start diastole) are
used. The idea behind this extrapolation is based on the fact that the isovolumic part of the pressure curve of an
ejecting beat is similar to these parts of a pressure curve during a non-ejecting beat (i.e. isovolumic). Consequently,
one can use these data points to fit a cosine wave, that results in an estimated pressure curve of a non-ejecting beat
and thus maximal isovolumic pressure.
B.
Schematic presentation of a pressure-volume loop showing the single-beat method to calculate Ees. Using the
estimated maximal isovolumic pressure, two data points on the end-systolic pressure-volume relationship (ESPVR) are
obtained and the slope (Ees) can be calculated.
50